Calculate the Mentzer Index and 5 additional discrimination indices to differentiate thalassemia trait from iron deficiency anemia in microcytic anemia.
The Mentzer Index (MCV/RBC) is the most widely used discrimination index to differentiate β-thalassemia trait from iron deficiency anemia (IDA) in patients with microcytic anemia (MCV <80 fL). A Mentzer index <13 suggests thalassemia trait, while >13 suggests iron deficiency. The index exploits a key pathophysiologic difference: thalassemia trait produces many small red cells (high RBC count, very low MCV), while IDA produces fewer hypochromic cells (low RBC count, moderately low MCV).
This calculator computes six established discrimination indices simultaneously — Mentzer, England-Fraser, Green-King, Sirdah, Ricerca, and Shine-Lal — and provides a consensus opinion based on the majority of indices. Multiple indices provide better diagnostic accuracy than any single index alone.
It is crucial to remember that these indices are screening tools only. Definitive diagnosis requires hemoglobin electrophoresis (HbA2 >3.5% confirms β-thalassemia trait) and iron studies (low ferritin confirms IDA). Both conditions can coexist, particularly in populations with high thalassemia prevalence.
Distinguishing thalassemia trait from iron deficiency is clinically important because treatment differs completely: iron supplementation for IDA vs genetic counseling for thalassemia trait. Unnecessary iron supplementation in thalassemia can cause iron overload, while missing IDA delays treatment of a reversible condition.
These indices are especially valuable in resource-limited settings where hemoglobin electrophoresis may not be readily available, and for initial screening in primary care before specialist referral.
Mentzer Index = MCV / RBC count <13 → Thalassemia trait >13 → Iron deficiency England-Fraser = MCV − RBC − (5 × Hb) − 3.4 <0 → Thalassemia trait Green-King = MCV² × RDW / (Hb × 100) <65 → Thalassemia trait Sirdah = MCV − RBC − (3 × Hb) <27 → Thalassemia trait Ricerca = RDW / RBC <3.3 → Thalassemia trait Shine-Lal = MCV² × MCH / 100 <1530 → Thalassemia trait
Result: Mentzer Index 12.4 — Thalassemia Trait Likely
MCV 68 / RBC 5.5 = Mentzer 12.4 (<13), suggesting thalassemia trait. The elevated RBC count (5.5 M/μL) and normal RDW (14%) are classic features. Five of six indices favor thalassemia. Confirmatory Hb electrophoresis showing HbA2 >3.5% would confirm β-thalassemia trait.
Beta-thalassemia trait (carrier state) affects ~1.5% of the global population, with highest prevalence in Mediterranean, Middle Eastern, South Asian, and Southeast Asian populations. Carriers are usually asymptomatic with mild microcytic anemia (Hb 10-12 g/dL). The key laboratory finding is elevated HbA2 (>3.5%) on hemoglobin electrophoresis. No treatment is needed, but genetic counseling is essential.
IDA is confirmed by low ferritin (<30 ng/mL is diagnostic, <12 ng/mL is definitive). In inflammatory states, ferritin may be falsely elevated — use transferrin saturation <16% or soluble transferrin receptor as alternatives. Once IDA is confirmed, always investigate the cause: menstrual losses, GI bleeding, celiac disease, poor dietary intake, or malabsorption.
Normal: HbA >95%, HbA2 2.0-3.5%, HbF <2%. β-thalassemia trait: HbA2 >3.5% (typically 4-6%), with or without mild HbF elevation. HbS trait: 35-45% HbS with normal HbA2. HbC trait: 35-45% HbC. Quantitative HPLC is the standard method for Hb variant identification.
The Mentzer index has approximately 85-90% sensitivity and 80-85% specificity in published studies. Accuracy varies by population and whether patients have concurrent iron deficiency and thalassemia. Using multiple indices in combination (as this calculator does) improves overall diagnostic accuracy to >90%.
Yes, and this is not uncommon in populations with high thalassemia prevalence. Iron deficiency can mask the elevated HbA2 in thalassemia trait (lowering HbA2 to near-normal levels). If iron deficiency is confirmed, treat with iron first, then recheck Hb electrophoresis once iron is replete to unmask potential thalassemia trait.
RDW (red cell distribution width) measures variability in red cell size. In iron deficiency, there is a mixture of normal-sized and microcytic cells (high RDW). In thalassemia trait, red cells are uniformly small (normal RDW). RDW >14.5% strongly favors iron deficiency over thalassemia trait.
Alpha-thalassemia trait (1-2 gene deletion) presents with microcytosis similar to beta-thalassemia trait, but HbA2 is NORMAL. If the clinical picture suggests thalassemia but Hb electrophoresis is normal, alpha-thalassemia should be considered. Diagnosis requires genetic testing (alpha-globin gene analysis) or exclusion of other causes of microcytosis.
If both partners carry thalassemia trait, each pregnancy has a 25% chance of thalassemia major. Genetic counseling is recommended for all patients diagnosed with thalassemia trait, especially before or during pregnancy. Carrier screening of the partner should be offered.
Most discrimination indices were developed and validated in adults. They can be used in children, but pediatric reference ranges for MCV and RBC count differ by age. In children under 6, physiologic macrocytosis means that MCV <70 fL (not <80 fL) may be more appropriate as a screening threshold for microcytosis.